MedTrace Logo

Computerized Antepartum Monitoring Using Non-invasive Fetal Ecg for High Risk Pregnancy

NCT04186975 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2019-12-05

No results posted yet for this study

Summary

The long term aim of this research is to evaluate a portable NI-FECG (Non-invasive fetal ECG) monitor (Holter NI-FECG) which can be used for regular remote assessment of fetal health in pregnancies at risk or to follow-up on treatments. The elaboration of a NI-FECG Holter device will offer new opportunities for fetal diagnosis and remote monitoring of problematic pregnancies because of its low-cost, non-invasiveness, portability and minimal set-up requirements.

Conditions

  • Cardiotocography

Interventions

DEVICE

Non-Invasive fetal ECG

Non-Invasive fetal ECG

DEVICE

Fetal heart rate monitor

Fetal heart rate monitor

Sponsors & Collaborators

  • Technion, Israel Institute of Technology

    collaborator OTHER

  • Rambam Health Care Campus

    lead OTHER

Principal Investigators

  • Oren Grunwald, MD · Rambam Health Care Campus

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-12-01
Primary Completion
2023-12-01
Completion
2023-12-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04186975 on ClinicalTrials.gov